Understanding the Uptake of Big Data in Health Care: Protocol for a Multinational Mixed-Methods Study by Wehrens, R. (Ron) et al.
Protocol
Understanding the Uptake of Big Data in Health Care: Protocol
for a Multinational Mixed-Methods Study
Rik Wehrens1*, PhD; Vikrant Sihag2,3*, PhD; Sandra Sülz1*, PhD; Hilco van Elten1*, PhD; Erik van Raaij1,2*, PhD;
Antoinette de Bont1*, PhD; Anne Marie Weggelaar-Jansen1,4*, PhD
1Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, Netherlands
2Rotterdam School of Management, Erasmus University Rotterdam, Rotterdam, Netherlands
3Department of Industrial Engineering & Innovation Sciences, Eindhoven University of Technology, Eindhoven, Netherlands
4School of Medical Physics and Engineering, University of Technology Eindhoven, Eindhoven, Netherlands
*all authors contributed equally
Corresponding Author:
Rik Wehrens, PhD
Erasmus School of Health Policy & Management
Erasmus University Rotterdam
Burgemeester Oudlaan 50
Rotterdam, 3062 PA
Netherlands
Phone: 31 10 408 8855
Email: wehrens@eshpm.eur.nl
Abstract
Background: Despite the high potential of big data, their applications in health care face many organizational, social, financial,
and regulatory challenges. The societal dimensions of big data are underrepresented in much medical research. Little is known
about integrating big data applications in the corporate routines of hospitals and other care providers. Equally little is understood
about embedding big data applications in daily work practices and how they lead to actual improvements for health care actors,
such as patients, care professionals, care providers, information technology companies, payers, and the society.
Objective: This planned study aims to provide an integrated analysis of big data applications, focusing on the interrelations
among concrete big data experiments, organizational routines, and relevant systemic and societal dimensions. To understand the
similarities and differences between interactions in various contexts, the study covers 12 big data pilot projects in eight European
countries, each with its own health care system. Workshops will be held with stakeholders to discuss the findings, our
recommendations, and the implementation. Dissemination is supported by visual representations developed to share the knowledge
gained.
Methods: This study will utilize a mixed-methods approach that combines performance measurements, interviews, document
analysis, and cocreation workshops. Analysis will be structured around the following four key dimensions: performance, embedding,
legitimation, and value creation. Data and their interrelations across the dimensions will be synthesized per application and per
country.
Results: The study was funded in August 2017. Data collection started in April 2018 and will continue until September 2021.
The multidisciplinary focus of this study enables us to combine insights from several social sciences (health policy analysis,
business administration, innovation studies, organization studies, ethics, and health services research) to advance a holistic
understanding of big data value realization. The multinational character enables comparative analysis across the following eight
European countries: Austria, France, Germany, Ireland, the Netherlands, Spain, Sweden, and the United Kingdom. Given that
national and organizational contexts change over time, it will not be possible to isolate the factors and actors that explain the
implementation of big data applications. The visual representations developed for dissemination purposes will help to reduce
complexity and clarify the relations between the various dimensions.
Conclusions: This study will develop an integrated approach to big data applications that considers the interrelations among
concrete big data experiments, organizational routines, and relevant systemic and societal dimensions.
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Introduction
Background
The potential of big data in health care is well-recognized in
the literature [1-4]. Big data are heterogeneous, complex, and
derived from many sources, for example, primary and secondary
electronic medical records, laboratory data, prescriptions,
imaging data, patient monitors, and telemedicine. Big data can
be captured by mobile apps, real-time location tracking, and
urban registries [1]. Patients, citizens, and other stakeholders
can collect big data, sometimes for other purposes than health
care. The framework often used to describe big data is “3V,”
which refers to the volume of data, variety of sources and types
of data, and velocity of the analysis [5-7]. Other authors have
added “veracity” (referring to credibility and “error-free”
analytics of big data) and “value” (referring to the impact of
big data usage on competitive advantage and performance) to
the 3V framework [8-10].
In health care, big data have been described as “encompassing
high volume, high variety biological, clinical, environmental,
and lifestyle information collected from single individuals to
large cohorts, in relation to their health and wellness status, at
one or several time points” [11]. With big data analytics,
routinely generated and collected health care data can be reused
for quality improvement (eg, quality registries, benchmarking,
and guideline development) [1], population management (eg,
early detection of diseases and accessibility), or improved
decision making (eg, treatment and cost reduction) [4].
Examples of big data analytics in health care are machine
learning, deep learning, image analytics, prediction algorithms,
and real-time event detection [4].
In medicine, research has focused on the technical dimensions
of big data, that is, how algorithms work and what is technically
accomplished with data, and the societal dimensions are
underrepresented in medical research literature. Including
societal dimensions is important as big data use in health care
faces many organizational, social, financial, and regulatory
challenges [10,11]. Moreover, organizations have to deal with
ethical dilemmas and public outcry [12]. Research on big data
technologies and applications in health care should be studied
not only as a set of techniques for data extraction, analysis, and
reuse, but also as a set of ideas and understandings of its use
[13]. Thus, big data research should include the societal
dimensions [10-13]. While new analytical techniques may hold
significant promise, embedding them sustainably in
organizational routines requires more than technical feasibility.
It also depends upon “sense-making work” in order to enhance
professional acceptability [14]. Similarly, while big data
technologies might be legally acceptable, public concerns
regarding ethical acceptability can create issues [15]. This
protocol therefore outlines an integral research approach that
sets out to understand the underlying patterns connected to the
societal, business, legal, ethical, political, and organizational
change issues surrounding big data applications in health care
[10,11].
Limited research in health care has tried to provide an integrated
analysis of big data pilots in varying organizational and social
contexts. Most papers in this field describe an empirical study
of a small-scale pilot, sometimes showing the results of big data
analysis [16,17]. For instance, information technology (IT)
literature (in health care and beyond) mostly describes promising
applications that are yet to be developed [18,19]. In addition,
most studies have a specific focus. Business administration
literature describes the business value of big data [20] or shows
how it can enhance organizational performance [21,22]. The
literature in philosophy and ethics centers on theoretical
discussions that only occasionally draw on rigorously analyzed
empirical examples [15,23]. Importantly, studies in the field of
health services research focus on legal frameworks and
principles, but often neglect how such frameworks and principles
become embedded in organizational practices [24,25]. Hence,
little is known about how promising big data pilot projects get
integrated in the organizational work practices of care providers
or how they get embedded in the daily routines of health care
professionals and actually improve health care for all the actors
concerned (eg, patients, health care professionals, health care
organizations, IT companies, payers, and the society) [26].
A recent systematic literature review revealed that in order to
advance our understanding of big data value realization, research
should move beyond pilot levels and examine how work
practices, organizational models, and stakeholder interests
interact with big data technology practices [12]. Few studies
provide this integrated analysis of the interaction among the
development of concrete pilots, the organizations in which they
take place, and the health care systems of which they are a part.
Wang et al [27], for instance, developed an integrated
transformation model that seeks to investigate causal
relationships among big data analytics capability, IT-enabled
transformation practices, benefit dimensions, and business
values. The authors sought to understand how big data analytics
capability transforms organizational practices, thereby
generating potential benefits. Cohen et al [28] linked the major
legal, policy, and ethical issues raised by predictive analytics
to the life cycle phases of predictive analytics models.
Heitmueller et al [29] explored questions that policy makers
should consider when developing public policy for big data
usage in health care. Their approach distinguishes the following
three broad categories of barriers: normative barriers (including
cultural and ethical norms), market failures, and technocratic
barriers (related to technological issues and government
processes and regulations). Such studies offer important
advances toward an integrated understanding of big data
technologies and embedding them in organizations and societies.
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In this research protocol, we outline our research approach that
aims to add to the body of knowledge on embedding big data
applications and technologies in organizations and societies.
Applying a mixed-methods approach, our protocol describes
how we plan to conduct a detailed multidisciplinary analysis of
the interactions among concrete big data applications,
organizational routines, and relevant systemic and societal
dimensions. We will study how 12 big data applications
(developed in pilot projects within a European Union–funded
consortium of which we are also a part) strive to become
embedded in (1) the daily routines of health care professionals
and health care organizations; (2) stakeholder networks in health
care organizations with varying infrastructures, policies,
routines, and opportunities; and (3) the broader societal context.
The overall research question is as follows: How do big data
applications and technologies become embedded (or fail to
become embedded) in the daily practice of health care
professionals, in the health care organization, and in the society
at large?
Research Aim and Approach
This protocol describes research that will be conducted within
the context of a broad consortium that is experimenting with
12 big data pilot projects covering the following three themes:
population health and chronic disease management, oncology,
and industrialization of health care services [30]. The research
will aim to understand how big data applications become
embedded in the daily practice of professionals (or fail to do
so), in the health care organization (why or why not), and in the
society at large. To study the interrelations between the
applications to be developed in the pilots and the organizational
and societal contexts in which they are situated, we will use the
Nicolini dual “zooming in-zooming out” approach because
“practices are always immersed in a thick texture of
interconnections” [31]. We will zoom in to allow different
aspects to come to the fore and zoom out to facilitate
investigation of the interrelations among concrete big data
applications, organizational routines, and relevant systemic and
societal dimensions.
To position our work, it is important to note that we will not
only study single pilots and their individual contexts, but also
feed our insights back into the pilots during the course of the
projects. While the idea of transferring gained knowledge in
oral and written forms to a pilot shares affinities with action
research, our approach differs in two aspects. First, action
research traditionally includes multiple feedback loops, which
not only provide feedback on practical problems but also on
any incorporated changes to practice that result from this
feedback [32,33]. In contrast, our study focuses on developing
knowledge and providing feedback to the pilots, but not on the
consequent implementation of this feedback. Second, action
research usually focuses on enabling transformative change
through a simultaneous process of taking action and doing
research, often through a participatory process involving practice
members as coresearchers [33]. Instead, our study gives targeted
feedback to the pilot, without involving coresearchers in the
way action research does. Rather than conducting action
research, our study adopts the approach of “situated
intervention” by Zuiderent-Jerak [34]. This approach argues
that intervention and knowledge production are not opposites,
but can be productively combined. Situated intervention builds
on the idea that the intervention is not just about practice
improvement, but is simultaneously a generative mode of
knowledge production. Thus, through commuting between the
pilot practices, cocreation workshops with the pilot team
members, and theory building beyond the individual pilots, we
aim to both improve practice via actionable insights and produce
new knowledge [35].
We will collect data through a range of carefully aligned studies.
We investigate from various disciplinary perspectives how the
stakeholders in the 12 pilot projects work toward the
performance, embedding, legitimation, and value creation of
their big data applications (these dimensions are described
below). These pilots all concern innovative uses of big data in
health care, but have different purposes and deal with various
illnesses and treatments in several contexts (eight European
countries with different health care systems). To this end, our
study combines methods from many of the social sciences,
including health policy analysis, business administration,
innovation studies, organization studies, ethics, and health
services research. To clarify, this means that our research will
not use the big data collected in the 12 pilot projects, but will
study how these pilot projects work on dimensions of
performance, embedding, legitimation, and value creation.
A multidisciplinary approach is advisable for empirical studies
of big data value realization focusing on several dimensions of
analysis [12,36]. We will synthesize the data and compare
countries to explore similarities and differences in how big data
applications become embedded (or not) nationally. To capture
the interrelations among individual big data applications,
organizational routines, and relevant systemic and societal
dimensions, we have selected “performance,” “value creation,”
“embedding,” and “legitimation” as key theoretical heuristics.
For each of these concepts, we have developed a particular
research question (Table 1). In line with our aim to combine
study practices and provide feedback, we will visualize the
results of each question in easily accessible ways.
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Table 1. Key concepts and visualization.
Research questionMethodsHeuristic
How does the uptake of big data applications affect
health care performance in terms of patient satisfaction,
process outcomes, patient outcomes, and financial out-
comes?
Cocreation workshops to develop KPIsa and biannual performance
measurements
Performance
What underlying mechanisms can explain how big data
applications do or do not become embedded in organi-
zational routines?
Document analysis, semistructured interviews, focus groups, and
follow-up interviews
Embedding
What are the major country-specific facilitators and
barriers for the legal, moral, and societal legitimacy of
big data applications in health care?
Document analysis and semistructured interviewsLegitimation
Which stakeholder group captures which kind(s) of
value from big data applications; through which activi-
ties, partners, and resources is the value generated; and
how can big data applications sustainably be financed?
Cocreation workshops to develop business modelsValue creation
aKPIs: key performance indicators.
Performance fits the multidimensional character of public sector
organizations [37,38]. The notion of multidimensionality is a
central tenet of the distinction between financial and
nonfinancial performance, as well as between processes and
outputs/outcomes [39]. Following this design, we distinguish
patient satisfaction, process outcomes, patient outcomes, and
financial outcomes in an adjusted version of the balanced
scorecard [40]. Patient satisfaction is defined as the perceptions
and experiences of patients with health care delivery and the
results thereof. Process outcomes refer to the activities
undertaken in health care delivery (eg, hospitalization and visits
to the specialist). Patient outcomes are defined as the effects of
care on patients’ health status (eg, mortality rates). Financial
outcomes are the monetary implications for individuals,
organizations, and the society. The associated research question
is as follows: How does the uptake of big data applications
affect health care performance in terms of patient satisfaction,
process outcomes, patient outcomes, and financial outcomes?
The concept of embedding refers to the dynamic processes that
lead the big data applications developed in the pilots to become
integrated (or not) in the daily work practices of health care
professionals, organizations, and societies. Based on insights
from normalization process theory, we focus on the following
four dimensions of embedding: sense-making work (actors’
interpretations of what the application can add to work
processes), relational work (actors’ efforts in building a
community of practice around the application), operational work
(the work of actors involved in establishing new task divisions),
and appraisal work (formal and informal assessments conducted
by actors to assess the value of the application) [14,41]. Through
these four dimensions, we aim to develop insights into the
underlying mechanisms of embedding. The associated research
question is as follows: What underlying mechanisms can explain
how big data applications do or do not become embedded in
organizational routines?
We conceptualize legitimacy as containing legal, societal, and
moral dimensions [42]. The legal dimension refers to whether
the big data application complies with formal legislation and
official regulations. New regulations (or national policies) can
be expected to affect (possibly limit) the opportunities available
to the pilots (eg, the EU General Data Protection Regulation
[GPDR] legislation could have major consequences for pilots
working with international technology development partners).
The legal dimension is less straightforward than it appears, as
regulations are often diverse and might conflict in practice.
Most often legislation trails new technological developments,
creating a large gray area in which the application of a regulation
can be interpreted in various ways [15]. The societal dimension
addresses national policies and the social acceptability of big
data. Since regulation is shaped by and embedded in cultural
and social practices and policies, these constitute another
dimension of legitimacy. The moral dimension focuses on the
ethical discussions about big data in different countries. Informal
societal aspects (eg, societal perspectives on the sharing of
health data, ways in which big data are represented in popular
media, and the ethical framing of the debate) can be expected
to have consequences for the ways big data applications are
developed and legitimized. The associated research question is
as follows: What are the major country-specific facilitators and
barriers for the legal, moral, and societal legitimacy of big data
applications in health care?
The concept of value creation relates to the impact of big data
applications in terms of both benefits (qualitative or quantitative)
and costs for stakeholders (ie, anyone who affects or is affected
by the application) [43]. As different stakeholders in the health
care system have different perspectives on value [44], the
dimensions of value focus on the value needs of the various
stakeholders. Value dimensions are broader in scope and thus
different from performance dimensions. Moreover, each health
care system has its own unique stakeholder network. As such,
stakeholder evaluation and participation in the development
process will have a distinct inward impact on the success of big
data applications in each health care system. We will focus on
the value needs of the following various stakeholders usually
associated with health care systems: patients, health care
organizations and providers, IT companies, vendors, insurers,
and the society. The business modeling process suggested by
Osterwalder et al can be used to capture, understand, and
evaluate the value creation process [45]. Therefore, we will use
a business model framework adapted for big data applications
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in health care to better understand the influence of such
applications on the development and implementation of various
activities within a health care system. The associated research
question is as follows: Which stakeholder group captures which
kind(s) of value from each big data application; through which
activities, partners, and resources is the value generated; and
through which models of cost coverage can big data applications
be sustainably financed in different health care systems?
Methods
Our study base is multidisciplinary to incorporate the many
dimensions of big data applications and their mutual
interrelations [13,30,36]. The design combines qualitative and
quantitative research methods stemming from several social
sciences, including health policy analysis, business
administration, innovation studies, organization studies, ethics,
and health services research [14,15,39,44]. Various researchers
with backgrounds in these fields are collaborating in a team that
is embedded in the bigger European Union–funded consortium.
The performance of big data applications [30] will be monitored
over time with pilot-specific key performance indicators (KPIs).
It is important that the pilot teams develop their own KPIs with
researchers, because these teams possess specific knowledge
required to capture the changes in their performance. The KPIs
should reflect the multidimensionality of performance
underlying this study (patient satisfaction, process outcomes,
patient outcomes, and financial outcomes) [46]. We will
organize workshops for the 12 pilot teams in order to select
KPIs and tailor these to the patient cohort, particular big data
application, and aim of the pilot. KPIs will be included in the
set if the pilot team and our research group consider them
relevant, given the context and availability of reliable data. For
the set of relevant and feasible KPIs, data will be collected
periodically to allow comparison of performance over time.
KPIs are based on various data sources used in the pilots (eg,
administrative hospital data, electronic medical records, and
registries from regional health ministries). For each pilot, there
will be a baseline measurement referring to the period before
implementation of the big data application. Following the
baseline measurement, data will be collected every 6 months
during and after the implementation of the big data application,
unless this timing is not feasible or meaningful for the type of
pilot.
Since prior literature advocates using dashboards to organize
KPIs in a health care setting [eg 47], we will bundle KPIs into
dashboards, with visualization per performance dimension to
provide feedback to the pilot teams. This visualized feedback
will allow both researchers and pilot team members to monitor
performance within and across pilots. The information on the
KPI dashboards will be discussed periodically with pilot teams
to understand performance improvements and obtain insights
into the facilitating or hindering factors. At the end of the study
period, we will perform a comparative analysis across and within
pilots to assess whether or by how much performance has
improved during and after the implementation of the big data
application. Wherever possible and in close collaboration with
the pilots, the comparative analysis will relate to a granular unit
of analysis (eg, individual patient level).
To study embedding, data are needed from various health care
systems, because how rules and regulations are set depends on
different actors in the various health care systems [48]. Relevant
data to study organizational embedding processes include key
contextual documents, such as policy documents from national
government and intermediary bodies. At the organizational
level, we will analyze organizational strategy documents and
conduct semistructured interviews to provide insights into how
the different actors and factors involved in setting the pilot
influence the embedding of the big data applications in
organizational routines. Causal loop diagrams can be used to
identify underlying feedback mechanisms that facilitate or hinder
these embedding processes [48,49]. Causal loop diagrams derive
from a tradition of systems thinking in organizational studies
[50] and social sciences [51].
We will study the embedding of big data applications in the
following three different health care systems: the Dutch
regulated market-based system, Sweden’s decentralized system,
and Austria’s national health service. We will perform
face-to-face semistructured interviews with pilot members, key
organizational actors, and expert informants. The pilot team
members will help to identify the respondents who best
understand their specific big data pilot and context. At the start
of each interview, we will obtain documented consent to record
the interview. All recorded interviews will be transcribed
verbatim. We will also conduct a document analysis. During
the course of the study, pilot team members will collect relevant
documents (eg, minutes, policy documents, and relevant emails).
The interview material and documents will be qualitatively
coded (open, thematic, and axial coding) and analyzed in order
to select the 10 to 20 most important factors for a causal model
[48,49]. Researchers will draw an initial causal model to explain
the hurdles that need to be overcome to structurally embed the
big data application in organizational routines, taking
country-specific contextual elements into consideration. This
initial causal model will be member-checked at a workshop
with the pilot team members. After 6 months, we will conduct
follow-up interviews with the same respondents to gain new
insights into the embedding process. If necessary, we will adapt
the causal models to incorporate new developments. We will
discuss these new developments for member-checking purposes
at the periodic consortium meetings.
Building again on our approach to combine research and
intervention [34], the discussions triggered by the causal models
will serve as a way to transfer our findings back to the pilot
team members, allowing them to use the developed insights in
the underlying patterns and mechanisms that hinder or facilitate
embedding of big data applications. Specifically, pilot teams
could use such insights to improve the embedding process of
their big data application.
Legitimacy includes legal, societal, and moral dimensions.
Previous research by Custers et al [52] identified the following
six themes: (1) awareness and trust, (2) government policies
for personal data protection, (3) applicable laws and regulations,
and (4) their implementation, (5) supervision, and (6)
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enforcement. Rumbold and Pierscionek [53] compared seven
European countries to identify regulatory barriers for restrictions
on using health data for research and included both formal
legislation and informal social/cultural norms and routines as
aspects of informal legitimacy.
We will study the following three aspects of legitimacy: legal
(legislation and regulations), societal (social and cultural norms),
and moral legitimacy (ethical dimensions and informal norms).
Besides conducting document analysis and semistructured expert
interviews, we will perform desktop research to analyze policy
documents, news articles, scientific papers, presentations, and
gray literature for each of the eight countries. We will search
for policy strategies on big data or related terms (artificial
intelligence and digital health), news articles on big data
application in health care, and presentations on the topic given
by domain experts. The documents will be qualitatively coded
(open, thematic, and axial coding) and analyzed in order to
increase our understanding of various country-specific elements,
such as the organization of the national health system, concrete
examples of media discussions or debates about big data, and
specific legislation. We will also conduct 20 semistructured
interviews in person or over Skype (Microsoft Corp) per country
(n=160) with (1) health care professionals and management;
(2) ethical/legal experts; (3) technology/IT developers and data
scientists; (4) patient representatives and prominent actors in
public/societal debate; and (5) policy makers and other experts.
To identify relevant experts in each country, we will build on
the knowledge and relationships of the consortium partners,
who have an expert network in their country. Other respondents
will be identified via document analysis and the snowballing
method. At the start of each interview, we will obtain
documented consent to record the interview. The topic list will
be informed by document analysis and core theoretical concepts
from the report by Custers et al [52]. The transcripts of the
interviews will be qualitatively coded (open, thematic, and axial
coding) and analyzed to develop a detailed understanding of
the three dimensions of legitimacy for health-related big data
in each country [54].
We will share the results of our aggregated analysis with pilot
partners using infographics to visualize the core dimensions of
legitimacy for each country, producing insights into the national
facilitators and barriers for the uptake of big data applications.
Building on our approach to combine research and intervention,
the infographics can also be used by pilot partners to support
their implementation activities.
We will study value creation through cocreation workshops
with pilot team members. At these workshops, the researchers
will guide team members in developing a business model canvas
to gain an understanding of how their big data applications can
be made financially sustainable beyond the pilot stage [55]. The
business model canvas enables identification of key activities,
key resources, required partners, investment and operational
costs, (economic) outcomes, and main beneficiaries, as well as
the added value of big data for each pilot [56]. The business
model canvas will be discussed and refined at periodic meetings.
We will collect observational data about the process of business
model development, as well as the various versions of the
business models as design artifacts. We will analyze the
designed business model canvases across the pilots to understand
how big data applications impact value creation for various
stakeholders across countries and diseases. We will compare
business model canvases across the pilots to identify a limited
number of business model types for sustainable value creation
based on big data applications in health care. The aim is to
understand the business prospects of big data in the various
national health care systems and under which conditions the
business model could be sustainable and add value for patients,
providers, payers, and the society.
Results
The study was funded in August 2017. Data collection started
in April 2018 and will continue until September 2021. This
combined research approach is likely to lead to the following
expected results. First, a set of pilot-specific KPIs and
corresponding dashboards to monitor progress. Second, three
causal loop diagrams that visualize the underlying patterns and
mechanisms that hinder or facilitate embedding of big data
applications into broader organizational routines. Third,
infographics to visualize the core dimensions of legitimacy for
each country, producing insights into the national facilitators
and barriers for the uptake of big data applications. Fourth,
business model canvases per project to provide insights of value
creation.
All our anonymized data will be stored in a secure online
environment (BlackBerry Workspace) available to researchers
and pilot team leaders only. The study has been approved by
the ethics board of Erasmus Medical Center (MEC-2018-056)
and the ethics review board of Erasmus University (EA18-01).
The review board of Erasmus University checked if we are
GDPR compliant. Written informed consent for all participants
(including respondents of the interviews, and focus group and
workshop participants) will be obtained, and member checks
for all interviews will be applied.
Discussion
Need for an Integrated Sociotechnical Approach
To evaluate whether big data applications can be embedded in
health care systems and provide value for patients, providers,
payers, and the society, we need an integrated sociotechnical
approach that considers not only concrete experiments but also
organizational routines, as well as systemic and societal
dimensions. Only then will we be able to develop crucial insights
into the interdependencies among big data projects,
organizations, and systems required to support providers and
payers in their investment decisions and policymakers in shaping
their policy goals, ethical questions, and regulations for big
data.
Limitations
Our study is focused on the context of the uptake of big data,
concentrating on embedding big data applications and
technologies in organizations and societies. However, one could
question if health care is already in the embedding phase or still
in the phase of understanding how and when to use big data
applications, especially by small pilots [57].
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Dissemination of Findings
Our work will be disseminated at conferences and workshops,
and published in professional (trade) journals, on electronic
media, and in a series of research articles in peer-reviewed
journals. We will arrange a series of workshops, inviting
stakeholders from the various pilot projects and experts to
discuss the contents and the implications of our findings.
Dissemination will focus on developing graphic visualizations,
as these help to reduce complexity and capture the relations
between the dimensions. We will use dashboards to visualize
performance over time as measured by jointly developed KPIs.
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